Page last updated: 2024-11-07

coenzyme f420

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

coenzyme gamma-F420-2 : The amide obtained by formal condensation of the carboxylic acid group of F420-0 with the amino group of L-gamma-glutamyl-L-glutamic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID123996
CHEBI ID16848
SCHEMBL ID17365331
MeSH IDM0064096

Synonyms (23)

Synonym
factor f420
n-{n-[o-(7,8-didemethyl-8-hydroxy-5-deazariboflavin phospho)-(s)-lactyl]-gamma-l-glutamyl}-l-glutamate
f420-2
f4202
CHEBI:16848
n-(n-{o-[1-(8-hydroxy-2,4-dioxo-2,3,4,10-tetrahydropyrimido[4,5-b]quinolin-10-yl)-1-deoxy-d-ribityl-5-phospho]-(s)-lactyl}-gamma-l-glutamyl)-l-glutamic acid
f420
10(2h)-yl)-
d-ribitol,5-o-[[(1s)-2-[[(1s)-1-carboxy-4-[[(1s)-1,3-dicarboxypropyl]amino]-4-oxobutyl]amino]-1-methyl-2-oxoethoxy]hydroxyphosphinyl]-1-deoxy-1-(3,4-dihydro-8-hydroxy-2,4-dioxopyrimido[4,5-b]quinolin-
64885-97-8
C00876
coenzyme f420
coenzyme gamma-f420-2
coenzyme f(420)
DB03913
n-(n-l-lactyl-gamma-l-glutamyl)-l-glutamic acid phosphodiester of 7,8-didemethyl-8-hydroxy-5- deazariboflavin 5'-phosphate
cof420
SCHEMBL17365331
(3s,8s,11s,13r,16r,17s,18s)-13,16,17,18-tetrahydroxy-19-(8-hydroxy-2,4-dioxo-3,4-dihydropyrimido[4,5-b]quinolin-10(2h)-yl)-11-methyl-5,10-dioxo-12,14-dioxa-4,9-diaza-13-phosphanonadecane-1,3,8-tricarboxylic acid 13-oxide (non-preferred name)
Q412727
((4s)-4-carboxy-4-((2s)-2-((hydroxy(((2r,3s,4s)-2,3,4-trihydroxy-5-(8-hydroxy-2,4-dioxo-3,4-dihydropyrimido[4,5-b]quinolin-10(2h)-yl)pentyl)oxy)phosphoryl)oxy)propanamido)butanoyl)-l-glutamic acid
(2s)-2-[[(4s)-4-carboxy-4-[[(2s)-2-[hydroxy-[(2r,3s,4s)-2,3,4-trihydroxy-5-(2,4,8-trioxo-1h-pyrimido[4,5-b]quinolin-10-yl)pentoxy]phosphoryl]oxypropanoyl]amino]butanoyl]amino]pentanedioic acid
DTXSID501046816

Research Excerpts

Overview

Coenzyme F420 is a deazaflavin hydride carrier with a lower reduction potential than most flavins. It is a redox cofactor found in methanogens and in various actinobacteria.

ExcerptReferenceRelevance
"Coenzyme F420 is a deazaflavin hydride carrier with a lower reduction potential than most flavins. "( Molecular insights into the binding of coenzyme F420 to the conserved protein Rv1155 from Mycobacterium tuberculosis.
Abell, C; Barry, CE; Garboczi, DN; Gittis, AG; Mashalidis, EH; Tomczak, A, 2015
)
2.13
"Coenzyme F420 is a redox cofactor found in methanogens and in various actinobacteria. "( Biosynthetic versatility and coordinated action of 5'-deoxyadenosyl radicals in deazaflavin biosynthesis.
Begley, TP; Berteau, O; Decamps, L; Philmus, B, 2015
)
1.86
"Coenzyme F420 is a 5-deazaflavin. "( Si-face stereospecificity at C5 of coenzyme F420 for F420H2 oxidase from methanogenic Archaea as determined by mass spectrometry.
Kahnt, J; Pierik, AJ; Seedorf, H; Thauer, RK, 2005
)
2.05
"Coenzyme F420 is a 8-hydroxy-5-deazaflavin present in methanogenic bacteria. "( Studies on the biosynthesis of coenzyme F420 in methanogenic bacteria.
Jaenchen, R; Schönheit, P; Thauer, RK, 1984
)
2
"Coenzyme F420 is a 5-deazaflavin. "( Si-face stereospecificity at C5 of coenzyme F420 for F420-dependent glucose-6-phosphate dehydrogenase from Mycobacterium smegmatis and F420-dependent alcohol dehydrogenase from Methanoculleus thermophilicus.
Berk, H; Daniels, L; Klein, AR; Purwantini, E; Thauer, RK, 1996
)
2.01

Effects

ExcerptReferenceRelevance
"Coenzyme F420 has been assayed by high-performance liquid chromatography with fluorimetric detection; this permits quantification of individual coenzyme F420 analogs whilst avoiding the inclusion of interfering material. "( Changes in concentrations of coenzyme F420 analogs during batch growth of Methanosarcina barkeri and Methanosarcina mazei.
Peck, MW, 1989
)
2.01

Dosage Studied

ExcerptRelevanceReference
"1% of inhibition respectively, which showed that the impact of ZnO NPs on methane production was dosage dependant."( Long-term effect of ZnO nanoparticles on waste activated sludge anaerobic digestion.
Chen, Y; Mu, H, 2011
)
0.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (118)

TimeframeStudies, This Drug (%)All Drugs %
pre-199022 (18.64)18.7374
1990's23 (19.49)18.2507
2000's36 (30.51)29.6817
2010's33 (27.97)24.3611
2020's4 (3.39)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.21 (24.57)
Research Supply Index4.79 (2.92)
Research Growth Index4.58 (4.65)
Search Engine Demand Index44.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (3.36%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other115 (96.64%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]